|
|
Article: Center for Inherited Disease Research Adds Affymetrix Platform for Large-Scale Genotyping Services.
- Article from:
- Business Wire
- Article date:
- June 16, 2008
CopyrightCOPYRIGHT 2008 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
First Project to Focus on Identifying Genetic Causes of Type 2 Diabetes
SANTA CLARA, Calif. -- Affymetrix Inc. (Nasdaq:AFFX) today announced that the Center for Inherited Disease Research (CIDR) has adopted its Genome-Wide Human SNP Array 6.0 for large-scale genotyping and copy number projects. CIDR is making Affymetrix-based genotyping available to supporting members of the National Institutes of Health (NIH). The first study to take advantage of this new CIDR offering is a NIDDK-funded project to identify the genetic causes of type 2 diabetes in African-Americans.
Donald W. Bowden, Ph.D. is director of the Wake Forest University School of Medicine ...